Pacing supplement: Drugs with devices in the management of heart failure

Cardiac device therapy has changed the landscape of heart failure management in the past decade in patients with heart failure and reduced left ventricular ejection fraction (HFREF). This has shifted some of the focus away from pharmacotherapy. This review will highlight the importance and clinical benefit of first ‘optimising’ medical therapy by introducing new, proven medications, as opposed to accepting the standard pharmacological therapy, and then analyse how treatment regimens can be further refined after device insertion. Finally, we will discuss how pharmacotherapy may be used as an avenue to reduce the proportion of patients that do not respond to device therapy.

Source link

Related posts

Signs, Symptoms & Risk factors of heart diseases in men


Iodine and Global Iodine deficiency disorders


Mean entropy predicts implantable cardioverter-defibrillator therapy using cardiac magnetic resonance texture analysis of scar heterogeneity.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy